Prostate cancer
Showing of 6 results
Landmark Study Finds Limited Survival Benefit from Routine Hormone Therapy with Postoperative Radiation for Prostate Cancer
Research team led by UH Seidman Cancer Center and UCLA published results in The Lancet; Presented at the American Society of Clinical Oncology Genitourinary Symposium.
UH Seidman Cancer Center Researchers Find Real World Data Can Inform Care for Metastatic Castration-Resistant Prostate Cancer
Findings were published in JAMA Network Open.
UH Seidman Cancer Researchers: What is the ideal duration of hormone therapy for the treatment of prostate cancer?
Results published in JAMA Oncology.
University Hospitals Seidman Cancer Center Researchers Develop Easy-to-Use Tool that can Identify High- and Low-Risk Metastatic Prostate Cancer Patients Earlier
Results published in Nature Communications.
Team of Researchers, including University Hospitals Co–Senior Author, Finds not all Low-Grade Prostate Cancers are Low Risk
The study, published July 31 in the journal JAMA Oncology, found that one in six men with GG1 category cancer turns out to have intermediate- or high-risk cancer when other clinical features are considered in addition to biopsy results.
Novel Oral Hormone Therapy Shows Promising Results for Prostate Cancer Treatment with Radiation Therapy
A high impact study led by Daniel Spratt, MD, demonstrates the safety and efficacy of a novel oral hormone therapy, relugolix, in conjunction with radiation therapy for treating men with localized and advanced prostate cancer.